Highlights and Quick Summary
- Trade and Non-Trade Receivables Growth for the quarter ending September 30, 2022 was 0.6 (a 1745.99% increase compared to previous quarter)
- Year-over-year quarterly Trade and Non-Trade Receivables Growth decreased by -178.58%
- Annual Trade and Non-Trade Receivables Growth for 2021 was -0.76 (a -140.23% decrease from previous year)
- Annual Trade and Non-Trade Receivables Growth for 2020 was 1.89 (a 5.28% increase from previous year)
- Annual Trade and Non-Trade Receivables Growth for 2019 was 1.8 (a -379.69% decrease from previous year)
Visit stockrow.com/BDSX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Trade and Non-Trade Receivables Growth of Biodesix, Inc.
Most recent Trade and Non-Trade Receivables Growthof BDSX including historical data for past 10 years.Interactive Chart of Trade and Non-Trade Receivables Growth of Biodesix, Inc.
Biodesix, Inc. Trade and Non-Trade Receivables Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | 0.6 | 0.03 | -0.79 | – |
| 2021 | – | -0.76 | -0.48 | -0.0 | -0.76 |
| 2020 | – | – | 3.19 | 0.94 | 1.89 |
| 2019 | – | – | – | 0.0 | 1.8 |
| 2018 | – | – | – | – | -0.64 |
Business Profile of Biodesix, Inc.
Sector: Healthcare
Industry: Diagnostics & Research